andor

SMC Announces LOI to Acquire Chaintrade LTD.

Source Node:
Time Stamp: May 8, 2024 2:36 PM - Modified On: May 8, 2024 - Published By:
Source Cluster:
Republished By Plato

Boca Raton, Florida – May 8, 2024 – SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC: SMCE), an incubator company focused on acquisition and support of commercialized financial services and technology (Fintech) companies, is excited to announce they have signed an LOI to acquire Chaintrade LTD, an AI Fintech company. Chaintrade has developed an AI Powered Asset Trading Platform that allows users to trade any Equity, ETF, Commodity, and Index with the support of a personalized AI Powered trading assistant SMC has agreed to acquire the platform and looks forward

SMC Announces Marketing Agreement with Plato Technologies. Inc.

Source Node:
Time Stamp: April 19, 2024 5:44 AM - Modified On: April 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  BOCA RATON, FL / Plato / Amplifi / April 18,2024 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE) SMC / (PINK:SMCE) is pleased to announce a marketing agreement and collaboration with Plato Technologies Inc. Plato Technologies specializes in AI content disruption and AI management systems. The collaboration will enable the Company to market Plato's platform directly to web and content development teams. The companies have agreed on a revenue sharing agreement after deducting individual client acquisition costs. "This is just the beginning." stated Erik Blum CEO

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

Source Node:
Time Stamp: February 5, 2024 8:17 AM - Modified On: February 5, 2024 - Published By:
Source Cluster:
Republished By Plato

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

1,300 E-JEEPNEY ORDER COMMITMENTS IN THE PHILIPPINES FOR TEMBO FRANCISCO MOTORS JOINT VENTURE

Source Node:
Time Stamp: January 18, 2024 1:46 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

Orders pursuant to Tembo’s previously announced joint venture with Francisco Motors Established in 1947, Francisco Motor Corporation is the original pioneering jeepney manufacturer Total addressable market to electrify 200,000 existing jeepneys estimated to be worth US$10bn+ Tembo E-LV, a subsidiary of the NASDAQ listed B Corp, VivoPower, announced today that, pursuant to its definitive joint venture agreement with Francisco Motor Corporation, it has been advised by Francisco Motors of a total of 1,300 order commitments received from several leading jeepney co-operatives in the Philippines, including Laguna, First Isabela, Progressive, and

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced